Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Nov 21;75(1):161–171. doi: 10.1007/s00280-014-2626-2

Fig. 1.

Fig. 1

NCI-60 human tumor cell line screen data from t-CUPM treatment. 51 cell lines from various cancer types were screened according to the NCI-60 cell line screening procedure. Comparison of the NCI-60 data for t-CUPM to known FDA-approved targeted therapies is presented in Table 2